NSC |
Compound |
Enrichment |
Correlation |
NSC 720248 |
Null |
0.024108502230778 |
-0.20664556 |
NSC 722316 |
Null |
0.024108502230778 |
-0.15977339 |
NSC 732317 |
6,7-dichloro-2-methyl-3-(phenylthio)quinoxaline 1,4-dioxide |
0.024108502230778 |
-0.20712143 |
NSC 734977 |
Ethyl N-[4-(10-methyl-3-phenyl-4H-indolo[3,2-e][1,2,3]triazolo [1,5-a]pyrimidin-4-yl)butanoyl]glycinate |
0.024108502230778 |
0.48774254 |
NSC 742327 |
(3-Difluoromethyl-6,7-dimethyl-1,4-dioxy-quinoxalin-2-yl)-phenyl-methanone |
0.024108502230778 |
-0.16654493 |
NSC 763646 |
(E)-2-(2-(benzo[d][1,3]dioxol-5-yl)vinyl)-5-(3-methyl-1H-pyrazol-5-yl)-1,3,4-oxadiazole |
0.024108502230778 |
-0.24667641 |
NSC 128571 |
Ethanesulfonic acid, compd. with 2-chloro-5-[4-[2-chloro-4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) (8CI) |
0.0241085022307781 |
-0.32712255 |
NSC 149286 |
1,4-Pentadien-3-one, 1,5-di-3-pyridyl- |
0.0241085022307781 |
-0.39439028 |
NSC 294979 |
BLEOMYCIN-BAPP |
0.0241085022307781 |
0.19167543 |
NSC 3061 |
BW 50-63 |
0.0241085022307781 |
-0.22941179 |